Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Rhizarthrosis Surgery and Functional Recovery: Arthroplasty vs. Trapezectomy

NCT: NCT06078189 · RECRUITING

NCT IDNCT06078189
StatusRECRUITING
Start Date2023-11-24
Completion2028-12
SponsorClinique Bizet (OTHER)
First posted
Last updated

Brief Summary

Rhizarthrosis is a form of osteoarthritis that affects the trapeziometacarpal joint at the base of the thumb, which is more common in women over 50. Genetic and hormonal factors as well as the frequency of certain physical movements may contribute to its appearance. Surgical treatment is recommended if medical treatment fails, and trapezectomy is currently considered the standard method, although 3rd generation trapeziometacarpal prostheses are also available. The aim of this study is to compare the clinical and radiographic results after surgical treatment of rhizarthrosis: prosthesis versus trapezectomy.

Frequently Asked Questions

What is Rhizarthrosis Surgery and Functional Recovery: Arthroplasty vs. Trapezectomy?

Rhizarthrosis Surgery and Functional Recovery: Arthroplasty vs. Trapezectomy is a clinical trial registered under NCT06078189. Current status: RECRUITING.

What is the status of NCT06078189?

The current status of NCT06078189 (Rhizarthrosis Surgery and Functional Recovery: Arthroplasty vs. Trapezectomy) is: RECRUITING.

When did Rhizarthrosis Surgery and Functional Recovery: Arthroplasty vs. Trapezectomy start?

Rhizarthrosis Surgery and Functional Recovery: Arthroplasty vs. Trapezectomy started on 2023-11-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.